178 related articles for article (PubMed ID: 31632959)
21. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
[TBL] [Abstract][Full Text] [Related]
22. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.
Strasser R; Stadlmann J; Schähs M; Stiegler G; Quendler H; Mach L; Glössl J; Weterings K; Pabst M; Steinkellner H
Plant Biotechnol J; 2008 May; 6(4):392-402. PubMed ID: 18346095
[TBL] [Abstract][Full Text] [Related]
23. Exploring Site-Specific N-Glycosylation of HEK293 and Plant-Produced Human IgA Isotypes.
Göritzer K; Maresch D; Altmann F; Obinger C; Strasser R
J Proteome Res; 2017 Jul; 16(7):2560-2570. PubMed ID: 28516782
[TBL] [Abstract][Full Text] [Related]
24. Reduced immunogenicity of Arabidopsis hgl1 mutant N-glycans caused by altered accessibility of xylose and core fucose epitopes.
Kaulfürst-Soboll H; Rips S; Koiwa H; Kajiura H; Fujiyama K; von Schaewen A
J Biol Chem; 2011 Jul; 286(26):22955-64. PubMed ID: 21478158
[TBL] [Abstract][Full Text] [Related]
25. Preparation and biological activities of anti-HER2 monoclonal antibodies with fully core-fucosylated homogeneous bi-antennary complex-type glycans.
Tsukimura W; Kurogochi M; Mori M; Osumi K; Matsuda A; Takegawa K; Furukawa K; Shirai T
Biosci Biotechnol Biochem; 2017 Dec; 81(12):2353-2359. PubMed ID: 29090617
[TBL] [Abstract][Full Text] [Related]
26. CD16a with oligomannose-type
Subedi GP; Barb AW
J Biol Chem; 2018 Oct; 293(43):16842-16850. PubMed ID: 30213862
[TBL] [Abstract][Full Text] [Related]
27. Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens.
van Ree R; Cabanes-Macheteau M; Akkerdaas J; Milazzo JP; Loutelier-Bourhis C; Rayon C; Villalba M; Koppelman S; Aalberse R; Rodriguez R; Faye L; Lerouge P
J Biol Chem; 2000 Apr; 275(15):11451-8. PubMed ID: 10753962
[TBL] [Abstract][Full Text] [Related]
28. FUT8-Directed Core Fucosylation of N-glycans Is Regulated by the Glycan Structure and Protein Environment.
García-García A; Serna S; Yang Z; Delso I; Taleb V; Hicks T; Artschwager R; Vakhrushev SY; Clausen H; Angulo J; Corzana F; Reichardt NC; Hurtado-Guerrero R
ACS Catal; 2021 Aug; 11(15):9052-9065. PubMed ID: 35662980
[TBL] [Abstract][Full Text] [Related]
29. Glycosylation of Plant-Produced Immunoglobulins.
Göritzer K; Strasser R
Exp Suppl; 2021; 112():519-543. PubMed ID: 34687021
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures.
Bardor M; Loutelier-Bourhis C; Paccalet T; Cosette P; Fitchette AC; Vézina LP; Trépanier S; Dargis M; Lemieux R; Lange C; Faye L; Lerouge P
Plant Biotechnol J; 2003 Nov; 1(6):451-62. PubMed ID: 17134403
[TBL] [Abstract][Full Text] [Related]
31. N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearance.
Higel F; Sandl T; Kao CY; Pechinger N; Sörgel F; Friess W; Wolschin F; Seidl A
Eur J Pharm Biopharm; 2019 Jun; 139():123-131. PubMed ID: 30905778
[TBL] [Abstract][Full Text] [Related]
32. Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation.
Yang Q; An Y; Zhu S; Zhang R; Loke CM; Cipollo JF; Wang LX
ACS Chem Biol; 2017 Jun; 12(6):1665-1673. PubMed ID: 28452462
[TBL] [Abstract][Full Text] [Related]
33. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
Hodoniczky J; Zheng YZ; James DC
Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
[TBL] [Abstract][Full Text] [Related]
34. Human IgE is efficiently produced in glycosylated and biologically active form in lepidopteran cells.
Bantleon F; Wolf S; Seismann H; Dam S; Lorentzen A; Miehe M; Jabs F; Jakob T; Plum M; Spillner E
Mol Immunol; 2016 Apr; 72():49-56. PubMed ID: 26943931
[TBL] [Abstract][Full Text] [Related]
35. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
Forthal DN; Gach JS; Landucci G; Jez J; Strasser R; Kunert R; Steinkellner H
J Immunol; 2010 Dec; 185(11):6876-82. PubMed ID: 21041724
[TBL] [Abstract][Full Text] [Related]
36. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry.
Valmu L; Alfthan H; Hotakainen K; Birken S; Stenman UH
Glycobiology; 2006 Dec; 16(12):1207-18. PubMed ID: 16880503
[TBL] [Abstract][Full Text] [Related]
37. Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection.
Boeggeman E; Ramakrishnan B; Pasek M; Manzoni M; Puri A; Loomis KH; Waybright TJ; Qasba PK
Bioconjug Chem; 2009 Jun; 20(6):1228-36. PubMed ID: 19425533
[TBL] [Abstract][Full Text] [Related]
38. A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners.
Holborough-Kerkvliet MD; Mucignato G; Moons SJ; Psomiadou V; Konada RSR; Pedowitz NJ; Pratt MR; Kissel T; Koeleman CAM; Tjokrodirijo RTN; van Veelen PA; Huizinga T; van Schie KAJ; Wuhrer M; Kohler JJ; Bonger KM; Boltje TJ; Toes REM
Glycobiology; 2023 Oct; 33(9):732-744. PubMed ID: 37498177
[TBL] [Abstract][Full Text] [Related]
39. Ca2+-dependent structural changes in the B-cell receptor CD23 increase its affinity for human immunoglobulin E.
Yuan D; Keeble AH; Hibbert RG; Fabiane S; Gould HJ; McDonnell JM; Beavil AJ; Sutton BJ; Dhaliwal B
J Biol Chem; 2013 Jul; 288(30):21667-77. PubMed ID: 23775083
[TBL] [Abstract][Full Text] [Related]
40. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
